azd4694 and rasagiline

azd4694 has been researched along with rasagiline* in 1 studies

Other Studies

1 other study(ies) available for azd4694 and rasagiline

Article	Year
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [ NeuroImage. Clinical, 2019, Volume: 24 [. To test the hypothesis that the MAO-B inhibitor, rasagiline reduces [. Six individuals (4: PSP; 2: cognitively unimpaired, CU) underwent [. The post-rasagiline regional SUV was reduced on average by 69-89% in PSP, and 53-81% in CU. The distributions of post-rasagiline [. Similar to AD, the interpretation of [ Topics: Aged; Aged, 80 and over; Aminopyridines; Benzofurans; Female; Humans; Hydrocarbons, Fluorinated; Indans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurofibrillary Tangles; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins	2019

Article

Year

Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [

NeuroImage. Clinical, 2019, Volume: 24

[. To test the hypothesis that the MAO-B inhibitor, rasagiline reduces [. Six individuals (4: PSP; 2: cognitively unimpaired, CU) underwent [. The post-rasagiline regional SUV was reduced on average by 69-89% in PSP, and 53-81% in CU. The distributions of post-rasagiline [. Similar to AD, the interpretation of [

Topics: Aged; Aged, 80 and over; Aminopyridines; Benzofurans; Female; Humans; Hydrocarbons, Fluorinated; Indans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurofibrillary Tangles; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins

2019